Literature DB >> 19101037

Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water.

S Mompelat1, B Le Bot, O Thomas.   

Abstract

Among all emerging substances in water, pharmaceutical products (PPs) and residues are a lot of concern. These last two years, the number of studies has increased drastically, however much less for water resources and drinking water than for wastewater. This literature review based on recent works, deals with water resources (surface or groundwater), focusing on characteristics, occurrence and fate of numerous PPs studied, and drinking water including water quality. Through this review, it appears that the pharmaceutical risk must be considered even in drinking water where concentrations are very low. Moreover, there is a lack of research for by-products (metabolites and transformation products) characterization, occurrence and fate in all water types and especially in drinking water.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101037     DOI: 10.1016/j.envint.2008.10.008

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  64 in total

1.  Application of surrogates, indicators, and high-resolution mass spectrometry to evaluate the efficacy of UV processes for attenuation of emerging contaminants in water.

Authors:  Sylvain Merel; Tarun Anumol; Minkyu Park; Shane A Snyder
Journal:  J Hazard Mater       Date:  2014-09-16       Impact factor: 10.588

2.  Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.

Authors:  M Rosa Boleda; Elida Alechaga; Encarnación Moyano; M Teresa Galceran; Francesc Ventura
Journal:  Environ Sci Pollut Res Int       Date:  2014-04-24       Impact factor: 4.223

3.  Occurrence of pharmaceuticals in municipal wastewater, in the recipient water, and sedimented particles of northern Lake Päijänne.

Authors:  Petra C Lindholm-Lehto; Heidi S J Ahkola; Juha S Knuutinen; Sirpa H Herve
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-03       Impact factor: 4.223

4.  Seasonal variation of pharmaceutically active compounds in surface (Tagus River) and tap water (Central Spain).

Authors:  Y Valcárcel; S González Alonso; J L Rodríguez-Gil; A Castaño; J C Montero; J J Criado-Alvarez; I J Mirón; M Catalá
Journal:  Environ Sci Pollut Res Int       Date:  2012-07-31       Impact factor: 4.223

5.  Risk estimation and annual fluxes of emerging contaminants from a Scottish priority catchment to the estuary and North Sea.

Authors:  Zulin Zhang; Melanie Lebleu; Mark Osprey; Christine Kerr; Estelle Courtot
Journal:  Environ Geochem Health       Date:  2017-06-28       Impact factor: 4.609

6.  Investigation of pharmaceutical metabolites in environmental waters by LC-MS/MS.

Authors:  Emma Gracia-Lor; María Ibáñez; Tatiana Zamora; Juan V Sancho; Félix Hernández
Journal:  Environ Sci Pollut Res Int       Date:  2014-01-10       Impact factor: 4.223

7.  Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment.

Authors:  Anne Bayer; Robert Asner; Walter Schüssler; Willi Kopf; Klaus Weiß; Manfred Sengl; Marion Letzel
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-06       Impact factor: 4.223

8.  Occurrence of cardiovascular drugs in the sewage-impacted Vistula River and in tap water in the Warsaw region (Poland).

Authors:  Joanna Giebułtowicz; Albert Stankiewicz; Piotr Wroczyński; Grzegorz Nałęcz-Jawecki
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-21       Impact factor: 4.223

9.  Aquatic photochemistry of paracetamol in the presence of dissolved organic chromophoric material and nitrate.

Authors:  Juhani Peuravuori
Journal:  Environ Sci Pollut Res Int       Date:  2012-01-13       Impact factor: 4.223

10.  Androgens, oestrogens, and progesterone concentrations in wastewater purification processes measured with capillary electrophoresis.

Authors:  Heli Sirén; Samira El Fellah
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-31       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.